Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychological distress and dyadic trust in Italian women awaiting colposcopy after positive cervical cancer screening: a cross-sectional study.

BMC women's health·2026
Same author

2026 International Society for the Study of Vulvovaginal Disease terminology for vulvar intraepithelial neoplasia and squamous intraepithelial lesions.

American journal of obstetrics and gynecology·2026
Same author

Unleashing the potential of mRNA-seq to uncover the microbiome structure and their crosstalk with host cells: the vulvar ecosystem.

Microbiome·2026
Same author

Vulvar Low-Grade Squamous Intraepithelial Lesion (LSIL) and Small Condyloma are Overlapping Clinicopathologic Entities.

Journal of lower genital tract disease·2026
Same author

Ciliated Cells Drive Critical STING-Mediated Tumor Suppression in the Fallopian Tube Epithelium.

Cancer research·2026
Same author

It Mite Not Be Graft-Versus-Host Disease: Frequency and Clinical Features of Demodex Folliculitis After Allogeneic Hematopoietic Cell Transplantation.

Transplantation and cellular therapy·2026
Same journal

Diagnostic Accuracy of MiRNA Panels for Endometrial Cancer: A Systematic Review and Meta-Analysis.

Journal of lower genital tract disease·2026
Same journal

Diagnostic Strategies After Negative Colposcopy in High-Grade Cervical Cytology: A Multicenter Randomized Trial.

Journal of lower genital tract disease·2026
Same journal

Bacterial and Fungal Profiles in Mixed Vaginitis Versus Bacterial Vaginosis.

Journal of lower genital tract disease·2026
Same journal

ASCCP President 's Message.

Journal of lower genital tract disease·2026
Same journal

Human Papillomavirus Test Agreement Between Self-Collected Vaginal and Clinician-Collected Cervical Specimens.

Journal of lower genital tract disease·2026
Same journal

Awards presented as part of the ASCCP 2026 Scientific Meeting on Anogenital & HPV-Related Diseases.

Journal of lower genital tract disease·2026
See all related articles

Related Experiment Video

Updated: Sep 9, 2025

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

17.5K

Interobserver Variation in Vulvar Squamous Cell Cancer Depth of Invasion Using Two Measurement Methods.

Jesse Carroll1, Tania Day, Jill Allbritton2

  • 1Maternity and Gynaecology, John Hunter Hospital, Newcastle, New South Wales, Australia.

Journal of Lower Genital Tract Disease
|September 2, 2025
PubMed
Summary
This summary is machine-generated.

The new FIGO 2021 method for measuring depth of invasion in vulvar cancer shows higher interobserver variation than the old method. This difference impacts clinical decisions for vulvar squamous cell carcinoma staging.

Keywords:
depth of invasioninterobserver variationvulvar cancer stagingvulvar squamous cell cancer

More Related Videos

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting
05:34

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

Published on: November 20, 2015

33.0K
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

3.1K

Related Experiment Videos

Last Updated: Sep 9, 2025

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

17.5K
A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting
05:34

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

Published on: November 20, 2015

33.0K
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

3.1K

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Surgical Oncology

Background:

  • Depth of invasion (DOI) is critical for predicting nodal metastasis risk in vulvar squamous cell carcinoma (vSCC).
  • International guidelines for measuring DOI have diverged, with some adopting the FIGO 2021 "New" method and others retaining the FIGO 2009 "Old" method.
  • This divergence necessitates evaluating the impact of each method on diagnostic consistency.

Purpose of the Study:

  • To compare the interobserver variation in measuring depth of invasion for vSCC using the FIGO 2009 "Old" and FIGO 2021 "New" measurement strategies.
  • To assess the clinical implications of differing DOI measurement methods on vSCC staging and management decisions.

Main Methods:

  • Ten pathologists measured DOI on 50 vSCC images (0.1-3 mm DOI) using both Old and New FIGO methods.
  • Statistical analyses included ANOVA, Student's t-test, and kappa statistics to evaluate interobserver agreement.
  • Discrepancies in measurements, particularly those crossing the 1 mm threshold, were analyzed.

Main Results:

  • The Old method resulted in a larger mean DOI (1.3 mm) compared to the New method (0.9 mm; p < .001).
  • Higher interobserver variation was observed with the New method (68% disagreement spanning 1 mm) compared to the Old method (53% disagreement; κ = 0.6 vs 0.65).
  • Interobserver variation was lower with the Old method when at least two pathologists measured DOI >1 mm (30/36 cases; mean difference = -0.1 mm).

Conclusions:

  • The FIGO 2021 DOI measurement method demonstrates greater interobserver variability than the FIGO 2009 method, particularly for tumors with DOI >1 mm.
  • The current lack of international consensus and limited clinical outcome data for the New method warrant a re-evaluation of the 2021 FIGO staging guidelines.
  • Standardizing DOI measurement is crucial for accurate vSCC staging and patient management.